Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: SOP for End Point Determination in Granulation via NIR – V 2.0

Posted on By

This SOP defines the procedure for determining the end point of wet granulation using Near Infrared Spectroscopy (NIR). The goal is to identify the optimal moisture level and ensure batch-to-batch granule consistency by integrating real-time PAT tools into process control decisions.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Dissolution Method for Coated Beads in Capsules – V 2.0

Posted on By

This SOP defines the step-by-step procedure for the development, optimization, and validation of a dissolution method intended for pharmaceutical dosage forms comprising coated beads within hard gelatin or HPMC capsules. It ensures reproducible drug release profiling, detection of burst release or incomplete release, and meets regulatory expectations for modified-release formulations.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Development of Uniformity of Mass Method – V 2.0

Posted on By

This SOP outlines the procedure for developing and validating a method to assess the uniformity of mass of solid oral dosage forms such as tablets, hard gelatin capsules, and soft gelatin capsules. This ensures dosage consistency, regulatory compliance, and batch acceptance based on pharmacopeial specifications.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Preparation of Linearity Data Table – V 2.0

Posted on By

The purpose of this SOP is to define the standardized procedure for preparing a linearity data table as part of analytical method development and validation. It includes steps for sample preparation, data recording, regression analysis, and documentation to demonstrate the method’s ability to produce results that are directly proportional to the concentration of analyte across a specified range.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Calibration of HPLC Systems – V 2.0

Posted on By

This SOP defines the procedure for calibration of High-Performance Liquid Chromatography (HPLC) systems to ensure accurate and reliable performance in support of analytical method development and validation activities. Proper calibration maintains data integrity and complies with current Good Manufacturing Practices (cGMP).
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Qualification of Analytical Instruments – V 2.0

Posted on By

This SOP defines the standardized process for qualifying analytical instruments to ensure that they are installed correctly, operate as intended, and consistently perform within established parameters. The procedure aligns with regulatory requirements such as GMP, ICH, and 21 CFR Part 11.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Verification of Analytical Procedures – V 2.0

Posted on By

This SOP defines the step-by-step process for verifying analytical procedures prior to their adoption in routine quality control testing. The objective is to confirm that the method is suitable for its intended use under actual laboratory conditions.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Handling and Verification of Blank and Placebo Interference – V 2.0

Posted on By

The purpose of this SOP is to establish a systematic procedure to identify and assess potential interference from blank solutions and placebo matrices in analytical method development. It ensures that the analytical method is specific and suitable for the intended use without false positives or overlapping peaks.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

Posted on By

The purpose of this SOP is to provide detailed instructions for the calibration of UV-Visible spectrophotometers to ensure accurate wavelength, photometric, and stray light performance for reliable analytical testing in method development.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Qualification and Performance Verification of Analytical Balances – V 2.0

Posted on By

The purpose of this SOP is to outline the qualification process and periodic performance verification procedures for analytical balances to ensure they provide accurate, consistent, and reliable weight measurements as per GMP and ICH guidelines.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 29 30 31 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme